SMTL ID : 3gkw.1

Crystal structure of the Fab fragment of Nimotuzumab. An anti-epidermal growth factor receptor antibody

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-1-1-mer

Ligands

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.1: 7 residues within 4Å: Chain A: Q.39, A.40, P.41, T.91, A.92, F.93, T.118 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:A.40, A:F.93

1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)

1PE.2: 10 residues within 4Å: Chain A: Y.33, N.59, G.100, L.101 Chain B: H.31, Y.37, Y.96, S.97, V.99, W.101 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.33

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Talavera, A. et al., Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation. Cancer Res. (2009)

Release Date

2009-08-04

Peptides

Heavy chain of the antibody Nimotuzumab: A
Light chain of the antibody Nimotuzumab: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

Heavy chain of the antibody Nimotuzumab

Light chain of the antibody Nimotuzumab